CHF Solutions Stock Price - CHFS

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
After Hours
Last Trade
Last: $ 2.13 ◊ 0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type
CHF Solutions Inc CHFS NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.01 0.47% 2.13 2.26 2.06 2.12 2.12 18:01:29
Bid Price Ask Price Spread Spread % News
2.10 2.30 0.20 8.7% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
464 79,698 $ 2.13 $ 169,430 101,071 0.40 - 14.14
Last Trade Time Type Quantity Stock Price Currency
17:57:03 32 $ 2.13 USD

CHF Solutions Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 5.51M 2.58M $ -17.03M -44.23 - 273.07k
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

CHF Solutions News

Loading Messages....

Latest CHFS Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CHFS Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week2.752.842.052.2991151k-0.62-22.55%
1 Month2.62.922.052.491589k-0.47-18.08%
3 Months2.853.092.052.677395k-0.72-25.26%
6 Months44.892.053.5518124k-1.87-46.75%
1 Year1.1514.140.43.1266138k0.9885.22%
3 Years14.006220.60.414.9639578k-11.876-84.79%
5 Years113.4220.60.420.2619390k-111.27-98.12%

CHF Solutions Description

CHF Solutions Inc is an early-stage medical device company based in the US. It focuses on commercializing the Aquadex FlexFlow System. The Aquadex FlexFlow System is used for temporary and extended ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. It is designed to remove excess fluid ( primarily excess salt and water) from patients suffering from fluid overload who have failed diuretic therapy. The company operates through a single segment being Cardiac and coronary disease products.


Your Recent History
NASDAQ
CHFS
CHF Soluti..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.